Used in research settings to measure ischemia-modified albumin levels in human serum or plasma, this ELISA kit helps investigate early cardiac ischemia, particularly in cases where traditional biomarkers like troponin may not yet be elevated. It supports studies on acute coronary syndrome, myocardial infarction, and other ischemic conditions by providing a quantitative assessment of albumin modification due to ischemic stress. The assay is useful in clinical research for evaluating cardiovascular risk and improving diagnostic accuracy when combined with other markers. It is not intended for standalone diagnostic use but serves as a valuable tool in cardiovascular biomarker research.